Impact Factor
3.55
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.82
629 total citations
h5-index
28
h5 depth signal
Cited share
58.9%
83 of 141
Total citations
629
Citation footprint
Metric signal
3.83
External metric anchor
Self-citation
0.3%
2 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Italy
111
United Kingdom
96
Netherlands
83
United States
79
Canada
44
Citing Fields of Research
Digestive Disorders
282
Inflammatory Bowel Diseases & Infections
112
Liver & Colon Cancer
110
Liver Diseases
101
Oncology
77
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,133
Articles tracked across the journal lifetime
Indexed publication set
141
83 cited publications
Last 12 months
87
7.3 publications/month
Open access share
29.9%
26 OA publications in the last year
Leading citing country
Italy
111 citing publications
Leading citing field
Digestive Disorders
282 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v15n1,Feb. 2001-
v15n1,Feb. 2001-
Active Coverage
Research Focus & Classification
Indexed Subjects
Digestive Disorders
Broad Categories
Gastroenterology
Digestive Disorders
Liver & Colon Cancer
Liver Diseases
MeSH Descriptors
Gastrointestinal Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.bpg.2026.102156
Open DOI
Rising incidence of cancer in obesity
02
DOI 10.1016/j.bpg.2026.102155
Open DOI
Dietary exposures, microbial ecology and carcinogenesis: An integrated review
03
DOI 10.1016/j.bpg.2026.102154
Open DOI
The gut microbiome in immunotherapy – lessons learned from melanoma and implications for gastrointestinal tumors
04
DOI 10.1016/j.bpg.2026.102150
Open DOI
Insulin resistance and hepatic steatosis
05
06
DOI 10.1016/j.bpg.2026.102148
Open DOI
Microbiome-directed therapies in oncology: from animal models to clinical implementation
07
08
DOI 10.1016/j.bpg.2026.102151
Open DOI
Genetic and epigenetic factors in obesity
09
10
DOI 10.1016/j.bpg.2026.102146
Open DOI
The metabolic paradigm shift in gastroenterology and hepatology: Clinical applications of incretin-based co-agonists
Bibliographical & Catalog Notes
Imprint varies.
Each issue has also a distinctive title.
Also issued online.